HOXA11 · Western blot design guide

HOXA11 Western Blot Planning Guide

Plan a HOXA11 Western blot around the catalog-observed 34.5 kDa band, image-backed PB9218 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for HOXA11 (HOXA11): expected band 34.5 kDa, antibody PB9218, and guide-derived SDS-PAGE protocol steps
HOXA11 Western blot protocol sheet — expected band 34.5 kDa, antibody PB9218, controls and PMC citations. Open the full HOXA11 WB guide →

HOXA11 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 34.5 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control ⓘ Testis
Negative control ⓘ Appendix
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 34.5 kDa
ⓘ Localization Nucleus
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated HOXA11 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateEndometrium
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryPB9218 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected HOXA11 Western Blot Band Size?

Use the product-observed 34.5 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
34.5 kDaMatches the authoritative product WB observation.
34.5 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected HOXA11 appearancePlan around 34.5 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band34.5 kDa; use this as the primary experimental expectation.
Calculated mass34.5 kDa from UniProt P31270; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with PB9218.
Why is my band missing or off?
SituationLikely causeNext action
34.5 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for HOXA11 Western blot

🧪Use Testis as the first positive-control candidate and Appendix as the HPA Not detected negative candidate.
Positive control: Testis (Medium)
Negative control: Appendix (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for HOXA11

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Testis Reported tissue cells Medium Protein (HPA) HPA →
Endometrium Reported tissue cells Medium Protein (HPA) HPA →
Prostate Reported tissue cells Low Protein (HPA) HPA →
Placenta Reported tissue cells Low Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Appendix Reported tissue cells Not detected Protein (HPA) HPA →
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced HOXA11 Western Blot Tips

Deeper troubleshooting and optimisation questions for HOXA11, answered from its protein features.

Which band should guide the blot?
Use 34.5 kDa, the observation attached to the authoritative PB9218 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 34.5 kDa expectation.
Which positive control should I start with?
Start with Testis, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Appendix as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for HOXA11 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PB9218 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

HOXA11 Western Blot Reagents

Human/Mouse/Rat-reactive HOXA11 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for HOXA11 using PB9218; observed band 34.5 kDa
Anti-HOXA11 Antibody Picoband®
Cat # PB9218

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt P31270
  2. Human Protein Atlas — HOXA11
  3. PB9218 product record
  4. PMC6874533 — Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells (Experimental & molecular medicine, 2019)
  5. PMC3275521 — Expression of HOXA11 in the mid-luteal endometrium from women with endometriosis-associated infertility (Reproductive biology and endocrinology : RB&E, 2012)
  6. PMC10157525 — Cooperation between NSPc1 and DNA methylation represses HOXA11 expression and promotes apoptosis of trophoblast cells during preeclampsia (Acta biochimica et biophysica Sinica, 2023)